Construction at the Norton site is currently underway, with the new offerings anticipated to be operational by late 2027.
A key step to deliver RNAi therapeutics to diverse cell types and tissues beyond the liver from the collaboration of ...
RNAi therapeutics company Alnylam Pharmaceuticals has announced the planned expansion of its manufacturing facility in Norton ...
Ten of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump ...
Halozyme Therapeutics, Inc. (Halozyme) today announced that Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for RYBREVANT FASPROtm (amivantamab and ...
Mega-cap technology companies have come to embody America’s market might: innovative, dominant, and seemingly unstoppable.
Despite market gains, Harbor Long-Term Growers ETF returned 6.90% (NAV) in Q3. Read the full report to understand key drivers ...
Kane Biotech Inc. (the "Company", "Kane" or "Kane Biotech") announces that today it has completed its previously announced non-brokered private placement offering (the "Offering") of common shares of ...
Harbor Long Term Growers ETF returned 6.90% in Q3 2025, underperforming its benchmark. Read the full report to discover key ...
The macro and thematic equity research group founded by investor and trend spotter James van Geelen saw positive returns - up to 75% - on nearly all of their 2025 calls. Their electronic warfare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback